EPIDERMOLYSIS BULLOSA
Clinical trials for EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to heal fragile skin
Disease control Recruiting nowThis study is testing if adding an IV immunoglobulin (IV IgG) treatment to an existing gene therapy (VYJUVEK) helps wounds heal better in people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a severe genetic skin condition. The main goal is to see if this combination re…
Matched conditions: EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New gel offers hope for healing fragile skin in rare genetic condition
Disease control Recruiting nowThis study is testing whether Oleogel-S10 gel helps close wounds in people with two types of epidermolysis bullosa (EB), a rare genetic condition that causes fragile, blistering skin. Japanese children and adults with confirmed EB will apply the gel to their wounds for 45 days wh…
Matched conditions: EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC